Cart
sales@molnova.com
KRAS inhibitor C6ME
CAS No. ——
KRAS inhibitor C6ME( —— )
Catalog No. M16989 CAS No. ——
KRAS inhibitor C6ME is a small-molecule compound that blocks biochemical and cellular functions of KRASG12V in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameKRAS inhibitor C6ME
-
NoteResearch use only, not for human use.
-
Brief DescriptionKRAS inhibitor C6ME is a small-molecule compound that blocks biochemical and cellular functions of KRASG12V in vitro.
-
DescriptionKRAS inhibitor C6ME is a small-molecule compound that blocks biochemical and cellular functions of KRASG12V in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorRas
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight377.488
-
Molecular FormulaC23H27N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Namemethyl 3-((((2S,4R)-2-benzylpiperidin-4-yl)amino)methyl)-1H-indole-6-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fang Z, et al. Cell Chem Biol. 2018 Aug 14. pii: S2451-9456(18)30261-7.
2. Jansen JM, et al. PLoS One. 2017 Apr 6;12(4):e0174706.
molnova catalog
related products
-
1-AM
A potent, selective, covalent KRAS G12C inhibitor that selectively inhibit KRAS G12C-dependent signaling and cancer cell growth at sub-micromolar concentrations.
-
Antineoplaston A10(b...
Antineoplaston A 10 is a Ras inhibitor potentially for the treatment of glioma lymphoma astrocytoma and breast cancer.
-
CID-1067700
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases（Rab7 with a Ki of 13 nM).
